万古霉素粉末联合稀释聚维酮碘冲洗在高风险全关节置换术中预防感染
该回顾性队列研究比较高风险全关节置换术患者采用「万古-聚维酮碘方案」(VIP)与历史对照组的假体周围关节感染(PJI)发生率,VIP组1413例PJI发生率1.3%,对照组3251例为1.8%,风险降低27.8%,且未观察到相关并发症。
要点
- 高风险TJA患者使用VIP方案后PJI发生率为1.3%,历史对照组为1.8%。
- VIP方案与对照组相比PJI风险降低27.8%,且无继发性医疗并发症。
- 未增加万古霉素耐药肠球菌或耐药金黄色葡萄球菌,无急性肾损伤。
核心结论
- 稀释聚维酮碘冲洗联合局部万古霉素粉末方案在高风险全关节置换术患者中安全,可能降低PJI发生率。
研究设计与样本
- 单中心回顾性观察性队列研究,比较使用VIP方案的高风险TJA患者(1413例)与未使用VIP的历史高风险队列(3251例)。
主要发现
- VIP组PJI发生率为1.3%,历史对照组为1.8%,风险降低27.8%。
- 未观察到VIP使用相关的医疗并发症,未增加万古霉素耐药肠球菌或万古霉素耐药金黄色葡萄球菌,无局部万古霉素应用导致的急性肾损伤。
关键数值与推荐
- 高风险标准包括体重指数>40、活跃吸烟、美国麻醉医师协会分级≥3、免疫抑制/糖尿病、耐甲氧西林金黄色葡萄球菌定植、翻修手术。
- VIP方案为稀释聚维酮碘冲洗后、伤口闭合前应用万古霉素粉末。
- 主要终点为术后3个月内PJI。
临床怎么用
- 对于符合高风险标准的全关节置换术患者,可考虑采用稀释聚维酮碘冲洗联合局部万古霉素粉末方案以降低PJI风险。
局限性
- 本研究为回顾性观察性队列研究,非随机对照,证据等级有限。
- 当前PJI发生率较低,需多中心随机对照试验评估降低PJI风险的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dilute povidone-iodine lavage has been shown to be safe and effective in decreasing acute periprosthetic joint infection (PJI) following total joint arthroplasty (TJA). Vancomycin powder is reported to be effective in preventing infection in spine surgery. We hypothesize that a "vanco-povidone protocol" (VIP) for TJA patients at high risk for infection is safe and will decrease the rate of PJI. METHODS: High-risk TJA patients (body mass index >40, active smokers, American Society of Anesthesiologists ≥3, immunosuppression/diabetes, methicillin-resistant Staphylococcus aureus colonization, revision surgery) utilizing VIP were compared to a high-risk historical cohort not treated with VIP, at a single institution. VIP consisted of dilute povidone-iodine lavage followed by application of vancomycin powder prior to wound closure. Primary endpoint was PJI within 3 months postoperatively. RESULTS: The historical, high-risk control cohort consisted of 3251 patients with a PJI incidence of 1.8%. A total of 1413 subjects received the VIP protocol with a PJI incidence of 1.3%. There was a 27.8% risk reduction when compared to the control group of high-risk subjects not treated with the VIP. There were no medical complications secondary to the use of VIP, no increase in vancomycin-resistant enterococcus or vancomycin-resistant Staph aureus, and no cases of acute renal impairment secondary to application of the local vancomycin. CONCLUSIONS: PJI remains a common complication of TJA, especially in high-risk populations. This study indicates that a protocol of dilute povidone-iodine lavage combined with topical vancomycin powder is safe and may reduce PJI incidence in high-risk TJA patients. Due to low, current PJI rates, a multi-institutional randomized controlled trial is necessary to assess interventions that minimize the risk of PJI. LEVEL OF EVIDENCE: Retrospective Observational Cohort.
引用
- Iorio R, Yu S, Anoushiravani AA, et al. Vancomycin Powder and Dilute Povidone-Iodine Lavage for Infection Prophylaxis in High-Risk Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 32247676. doi:10.1016/j.arth.2020.02.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。